Resultados de procura - Steven P. Angus
- Mostrando 1 - 15 Resultados de 15
-
1
-
2
-
3
-
4
-
5
Kinome and Transcriptome Profiling Reveal Broad and Distinct Activities of Erlotinib, Sunitinib, and Sorafenib in the Mouse Heart and Suggest Cardiotoxicity From Combined Signal Tr... por Timothy J. Stuhlmiller, Jon S. Zawistowski, Xin Chen, Noah Sciaky, Steven P. Angus, Sean T. Hicks, Traci L. Parry, Wei Huang, Ju Youn Beak, Monte S. Willis, Gary L. Johnson, Brian C. Jensen
Publicado 2017Artigo -
6
New Mechanisms of Resistance to MEK Inhibitors in Melanoma Revealed by Intravital Imaging por Hailey E. Brighton, Steven P. Angus, Tao Bo, Jose Roques, Alicia C. Tagliatela, David B. Darr, Kübra Karagoz, Noah Sciaky, Michael L. Gatza, Norman E. Sharpless, Gary L. Johnson, James E. Bear
Publicado 2017Artigo -
7
GSK2801, a BAZ2/BRD9 Bromodomain Inhibitor, Synergizes with BET Inhibitors to Induce Apoptosis in Triple-Negative Breast Cancer por Samantha M. Bevill, José F. Olivares-Quintero, Noah Sciaky, Brian T. Golitz, Darshan Singh, Adriana S. Beltrán, Naim U. Rashid, Timothy J. Stuhlmiller, Andrew Hale, Nathaniel J. Moorman, Charlene Santos, Steven P. Angus, Jon S. Zawistowski, Gary L. Johnson
Publicado 2019Artigo -
8
PLK1 inhibition induces synthetic lethality in Fanconi anemia pathway-deficient acute myeloid leukemia por Aditya S. Sheth, Ka-Kui Chan, Sheng Liu, Jun Wan, Steven P. Angus, Steven D. Rhodes, Dana K. Mitchell, Christopher Davis, Maya Ridinger, Peter J.P. Croucher, Amer M. Zeidan, Aruna Wijeratne, Shaomin Qian, Ngoc Tung Tran, Elizabeth A. Sierra Potchanant
Publicado 2025Artigo -
9
Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains por Timothy J. Stuhlmiller, Samantha M. Miller, Jon S. Zawistowski, Kazuhiro Nakamura, Adriana S. Beltrán, John S. Duncan, Steven P. Angus, Kyla Collins, Deborah A. Granger, Rachel A. Reuther, Lee M. Graves, Shawn M. Gomez, Pei Fen Kuan, Peter J. Park, Xin Chen, Noah Sciaky, Lisa A. Carey, H. Shelton Earp, Jian Jin, Gary L. Johnson
Publicado 2015Artigo -
10
Enhancer Remodeling during Adaptive Bypass to MEK Inhibition Is Attenuated by Pharmacologic Targeting of the P-TEFb Complex por Jon S. Zawistowski, Samantha M. Bevill, Daniel R. Goulet, Timothy J. Stuhlmiller, Adriana S. Beltrán, José F. Olivares-Quintero, Darshan Singh, Noah Sciaky, Joel S. Parker, Naim U. Rashid, Xin Chen, James S. Duncan, Martin C. Whittle, Steven P. Angus, Sara H. Velarde, Brian T. Golitz, Xiaping He, Charlene Santos, David B. Darr, Kristalyn Gallagher, Lee M. Graves, Charles M. Perou, Lisa A. Carey, H. Shelton Earp, Gary L. Johnson
Publicado 2017Artigo -
11
Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma por Robert S. McNeill, Demitra A. Canoutas, Timothy J. Stuhlmiller, Harshil Dhruv, David Irvin, Ryan Bash, Steven P. Angus, Laura E. Herring, Jeremy M. Simon, Kasey Skinner, Juanita C. Limas, Xin Chen, Ralf S. Schmid, Marni B. Siegel, Amanda E.D. Van Swearingen, Michael Hadler, Erik P. Sulman, Jann N. Sarkaria, Carey K. Anders, Lee M. Graves, Michael E. Berens, Gary L. Johnson, C. Ryan Miller
Publicado 2017Artigo -
12
Redefining the MED13L syndrome por Abidemi Adegbola, Luciana Musante, Bert Callewaert, Patrı́cia Maciel, Hao Hu, Bertrand Isidor, Sylvie Picker‐Minh, Cédric Le Caignec, Barbara Delle Chiaie, Olivier Vanakker, Björn Menten, Annelies Dheedene, Nele Bockaert, Filip Roelens, Karin Decaestecker, João Silva, Gabriela Soares, Fátima Lopes, Hossein Najmabadi, Kimia Kahrizi, Gerald F. Cox, Steven P. Angus, John F. Staropoli, Ute Fischer, Vanessa Suckow, Oliver Bartsch, Andrew Chess, Hans‐Hilger Ropers, Thomas F. Wienker, Christoph Hübner, Angela M. Kaindl, Vera M. Kalscheuer
Publicado 2015Artigo -
13
Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial por Michael J. Fisher, Chie‐Schin Shih, Steven D. Rhodes, Amy E. Armstrong, Pamela L. Wolters, Eva Dombi, Chi Zhang, Steven P. Angus, Gary L. Johnson, Roger J. Packer, Jeffrey C. Allen, Nicole J. Ullrich, Stewart Goldman, David H. Gutmann, Scott R. Plotkin, Tena Rosser, Kent A. Robertson, Brigitte C. Widemann, Abbi E. Smith, Waylan Bessler, Yongzheng He, Su Jeong Park, Julie A. Mund, Jiang Li, Khadijeh Bijangi‐Vishehsaraei, Coretta Thomas Robinson, Gary Cutter, Bruce R. Korf, Chie‐Schin Shih, Amy E. Armstrong, Jaishri O. Blakeley, D. Wade Clapp
Publicado 2021Artigo -
14
Brigatinib causes tumor shrinkage in both NF2-deficient meningioma and schwannoma through inhibition of multiple tyrosine kinases but not ALK por Long‐Sheng Chang, Janet L. Oblinger, Abbi E. Smith, Marc Ferrer, Steven P. Angus, Eric Hawley, Alejandra M. Petrilli, Roberta L. Beauchamp, Lars Björn Riecken, Serkan Erdin, Ming Poi, Jie Huang, Waylan Bessler, Xiaohu Zhang, Rajarshi Guha, Craig J. Thomas, Sarah S. Burns, Thomas S.K. Gilbert, Li Jiang, Xiaohong Li, Qingbo Lu, Jin Yuan, Yongzheng He, Shelley A.H. Dixon, Andrea R. Masters, David R. Jones, Charles W. Yates, Stephen J. Haggarty, Salvatore La Rosa, D. Bradley Welling, Anat Stemmer‐Rachamimov, Scott R. Plotkin, James F. Gusella, Justin Guinney, Helen Morrison, Vijaya Ramesh, Cristina Fernández‐Valle, Gary L. Johnson, Jaishri O. Blakeley, D. Wade Clapp
Publicado 2021Artigo -
15
A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma por Clemens Krepler, Katrin Sproesser, Patricia Brafford, Marilda Beqiri, Bradley Garman, Min Xiao, Batool Shannan, Andrea Watters, Michela Perego, Gao Zhang, Adina Vultur, Xiangfan Yin, Qin Liu, Ioannis N. Anastopoulos, Bradley Wubbenhorst, Melissa Wilson, Wei Xu, Giorgos C. Karakousis, Michael D. Feldman, Xiaowei Xu, Ravi K. Amaravadi, Tara C. Gangadhar, David E. Elder, Lauren E. Haydu, Jennifer A. Wargo, Michael A. Davies, Yiling Lu, Gordon B. Mills, Dennie T. Frederick, Michal Barzily-Rokni, Keith T. Flaherty, Dave S.�B. Hoon, Michael J. Guarino, Joseph Bennett, R Ryan, Nicholas J. Petrelli, Carol L. Shields, Mizue Terai, Takami Sato, Andrew E. Aplin, Alexander Roesch, David B. Darr, Steven P. Angus, Rakesh Kumar, Ensar Halilovic, Giordano Caponigro, Sébastien Jeay, Jens Wuerthner, Annette O. Walter, Matthias Ocker, Matthew B. Boxer, Lynn M. Schuchter, Katherine L. Nathanson, Meenhard Herlyn
Publicado 2017Artigo
Ferramentas de procura:
Materias Relacionadas
Biology
Cancer research
Cell biology
Genetics
Gene
Medicine
Cancer
Internal medicine
Kinase
Kinome
Signal transduction
Bromodomain
Gene expression
MAPK/ERK pathway
Melanoma
Pathology
Transcription factor
BRD4
Breast cancer
Cell
Chemotherapy
Epigenetics
MEK inhibitor
Neurofibromatosis type 2
Oncology
PI3K/AKT/mTOR pathway
Phenotype
Promoter
Receptor
Receptor tyrosine kinase